Cargando…
Current status of silica-based nanoparticles as therapeutics and its potential as therapies against viruses
In the past decade, interest in nanoparticles for clinical indications has been steadily gaining traction. Most recently, Lipid Nanoparticles (LNP) have been used successfully to construct the SARS-CoV-2 mRNA vaccines for rapid pandemic response. Similarly, silica is another nanomaterial which holds...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9776486/ https://www.ncbi.nlm.nih.gov/pubmed/36566118 http://dx.doi.org/10.1016/j.antiviral.2022.105488 |